SpyGlass Pharma, Inc. SEC filings SGP
SpyGlass Pharma, Inc. has 92 filings in SEC EDGAR's recent list, going back to Jun 5, 2019. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 1, 2026 | Oct 1, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Other events
|
Mar 9, 2026 | Mar 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 17, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 13, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 13, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2026 | Feb 12, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4/A | Filing | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 10, 2026 | — |
| 4 | Insider transaction | Feb 10, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 9, 2026 | Feb 5, 2026 |
| S-8 | Employee stock plan registration | Feb 6, 2026 | — |
| 424B4 | Prospectus | Feb 6, 2026 | — |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| 3 | Initial insider ownership | Feb 5, 2026 | Feb 5, 2026 |
| CERT | Filing | Feb 5, 2026 | — |
| 8-A12B | Filing | Feb 5, 2026 | — |
| EFFECT | Filing | Jan 30, 2026 | — |
| CORRESP | Letter to the SEC | Jan 29, 2026 | — |
| CORRESP | Letter to the SEC | Jan 29, 2026 | — |
| CORRESP | Letter to the SEC | Jan 29, 2026 | — |
| S-1/A | Amended registration statement | Jan 29, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| CORRESP | Letter to the SEC | Jan 16, 2026 | — |
| S-1 | Registration statement | Jan 16, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2026 | — |
| DRS/A | Filing | Dec 10, 2025 | — |
| DRSLTR | Filing | Dec 9, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2025 | — |
| DRS | Filing | Sep 26, 2025 | — |
| D | Filing | Jun 5, 2025 | — |
| D | Filing | Jul 11, 2023 | — |
| D | Filing | Jan 5, 2021 | — |
| D | Filing | Jun 5, 2019 | — |
Showing 92 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SGP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1778922
- Former names
- SpyGlassPharma, Inc. (until Jun 5, 2025); SpyGlass Ophthalmics, Inc. (until Jan 5, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.